The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Defence Therapeutics Appoints Kwin Grauer As Interim Chief Executive Officer
PRIVATEAug 31, 2024•almost 2 years ago
Position
Chief Executive Officer
Company
Defence Therapeutics
Kwin Grauer
VancouverBiotechnologyHealth CareTherapeutics
Description
Defence Therapeutics Inc. announces the appointment of Kwin Grauer as interim Chief Executive Officer, replacing Sébastien Plouffe. This change comes as the Company moves from the preclinical stage towards a clinical stage.
Company Information
Company
Defence Therapeutics
Location
Vancouver, British Columbia, Canada
About
Defence Therapeutics is a publicly-traded clinical-stage biotechnology company working on engineering the next generation vaccines and ADC products using its proprietary platform. The core of Defence Therapeutics platform is the ACCUM® technology, which enables precision delivery of vaccine antigens or ADCs inside target cells and favoring their processing and activities. As a result, increased efficacy and potency can be reached against catastrophic illness such as cancer and infectious diseases.
VancouverBiotechnologyHealth CareTherapeutics